Taylor Chanel, Awadzi Rossby, Enoch Jamie, Dinah Christiana
Patient Author, London, UK.
London Northwest University Healthcare Trust, London, UK.
Ophthalmol Ther. 2024 Apr;13(4):851-860. doi: 10.1007/s40123-024-00893-3. Epub 2024 Feb 12.
The impact of visual impairment in the context of sickle cell disease is poorly understood. Despite the significant advancements over the past three decades in retinal imaging and in the understanding of molecular mechanisms that drive retinal neovascularization, there has been little improvement in the management of proliferative sickle cell retinopathy. This article is co-authored by a patient impacted by proliferative sickle cell retinopathy. She highlights her personal experience of sight loss from proliferative sickle cell retinopathy and the impact on her daily life and mental health. Subsequent to diagnosis and management of proliferative sickle cell retinopathy, she continues to live with irreversible sight loss and provides crucial insight from a patient's perspective into the broad lack of high-quality educational materials online and lack of understanding of the disease within the clinical community. This article aims to provide a strong narrative to emphasize the need for further qualitative and quantitative research in this area, to bring about the holistic step-change required to improve visual outcomes and eyecare for people with sickle cell disease.
镰状细胞病背景下视力损害的影响尚不清楚。尽管在过去三十年里,视网膜成像以及对驱动视网膜新生血管形成的分子机制的理解取得了重大进展,但增殖性镰状细胞视网膜病变的治疗几乎没有改善。本文由一位受增殖性镰状细胞视网膜病变影响的患者共同撰写。她讲述了自己因增殖性镰状细胞视网膜病变而失明的个人经历,以及这对她日常生活和心理健康的影响。在增殖性镰状细胞视网膜病变得到诊断和治疗后,她仍生活在不可逆的视力丧失中,并从患者角度提供了关键见解,指出在线上广泛缺乏高质量教育材料以及临床界对该疾病缺乏了解的问题。本文旨在提供一个有力的叙述,强调在这一领域进行进一步定性和定量研究的必要性,以实现改善镰状细胞病患者视觉预后和眼保健所需的全面性逐步改变。